LNTH ▲ +0.2% - Lantheus Holdings, Inc. $LNTH - Lantheus Presents Data from Two Pivotal Phase 3 Studies of TAUKLARIFY (Florquinitau F 18 Injection) PET Imaging in Early Alzheimer’s Disease 16-NOV-2026 09:00 AM ET